Autoimmune Hepatitis Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Autoimmune Hepatitis Market is segmented By Therapeutics (Immunosuppressive Drugs, Corticosteroids, Biologics), By Drug Pipeline (Early-stage Drugs, L....
Autoimmune Hepatitis Market Size
Market Size in USD
CAGR5.6%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 5.6% |
| Market Concentration | High |
| Major Players | Novartis, Gilead Sciences, Pfizer, Merck & Co., Bristol-Myers Squibb |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Autoimmune Hepatitis Market Analysis
The autoimmune hepatitis market is estimated to be valued at USD 127.3 Mn in 2024 and is expected to reach USD 186.9 Mn by 2031, growing at a compound annual growth rate (CAGR) of 5.6% from 2024 to 2031. The growing prevalence of autoimmune hepatitis across the globe is the major factor driving the growth of the market. According to recent studies, autoimmune hepatitis affected approximately 20-50 individuals per million worldwide.